Cote d'Ivoire Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Moxidectin for LF, Cote d'Ivoire (DOLF)
Condition: Lymphatic Filariasis Interventions: Drug: IA (IVM+ ABZ); Drug: MoxA (Mox + ABZ); Drug: IDA (IVM + DEC + ABZ); Drug: MoxDA (Mox + DEC + ABZ) Sponsors: Washington University School of Medicine; Case Western Reserve University; Regional Hospital of Agboville, Southern Cote d'Ivoire Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials